Neurology

Advertisement
  • FDA trims use of contentious Alzheimer's drug amid backlash

    Washington–A month after approving a controversial new Alzheimer's drug, U.S. health regulators on Thursday signed off on new prescribing instructions that are likely to limit its use. The Food and Drug Administration said the change is intended to address confusion among 
    person,indoor,sitting,man,table,holding,hand,young,standing,computer,group,phone